Kovo HealthTech Corporation provided revenue guidance for the year of 2022. In its initial 2022 Guidance, the Company is anticipating Pro Forma Revenues of CAD 15,000,000 (USD 12,000,000), a 30% increase in year-over-year organic growth excluding additional acquisitions in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | +20.00% |
|
0.00% | 0.00% |
07-09 | Kovo HealthTech Corporation Announces CEO Changes | CI |
06-14 | Kovo HealthTech Corporation Announces CFO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.26M | |
-5.50% | 29.41B | |
+37.09% | 9.45B | |
+31.59% | 4.34B | |
-36.88% | 2.39B | |
-6.48% | 1.66B | |
-23.84% | 1.32B | |
-42.92% | 977M | |
-3.96% | 860M | |
-50.69% | 687M |
- Stock Market
- Equities
- KOVO Stock
- News Kovo HealthTech Corporation
- Kovo HealthTech Corporation Provides Revenue Guidance for the Year of 2022